Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Apr;65(4):1566–1569. doi: 10.1128/iai.65.4.1566-1569.1997

Salmonella typhimurium aroA, htrA, and aroD htrA mutants cause progressive infections in athymic (nu/nu) BALB/c mice.

K Sinha 1, P Mastroeni 1, J Harrison 1, R D de Hormaeche 1, C E Hormaeche 1
PMCID: PMC175172  PMID: 9119506

Abstract

Athymic (nu/nu) BALB/c mice and their euthymic (nu/+) littermates were inoculated intravenously with live attenuated vaccine strains of Salmonella typhimurium. All strains caused progressive infections in the athymic mice but not in their euthymic littermates. Athymic mice given strain SL3261, an aroA derivative of SL1344, in doses between log 4.7 and 5.7 CFU were all severely ill and were killed by weeks 4 to 5. Athymic mice given log 4.7 CFU of a derivative of S. typhimurium C5 carrying a mutation in htrA, encoding a stress protein, were ill and were killed by week 7 in one experiment but survived to week 13 in another. Athymic mice given log 4.6 CFU of a C5 aroD htrA double mutant were ill and were killed at week 7. Athymic mice given SL3261 had high bacterial counts in the reticuloendothelial system at 4 weeks. Athymic mice given SL3261 or C5 htrA made immunoglobulin G3 (IgG3) (and to a lesser extent IgM) antibody to lipopolysaccharide (LPS), whereas euthymic mice made IgM, IgG1, IgG2a, IgG2b, and IgG3 anti-LPS antibodies. The results indicate that both aroA and htrA strains will produce slow, progressively lethal infections in athymic mice, that the htrA strain is more attenuated than the aroA strain as measured by time to death in this model, and that IgG3 anti-LPS antibody alone cannot suppress the progress of infections by very attenuated strains in athymic mice.

Full Text

The Full Text of this article is available as a PDF (138.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chabalgoity J. A., Khan C. M., Nash A. A., Hormaeche C. E. A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection. Mol Microbiol. 1996 Feb;19(4):791–801. doi: 10.1046/j.1365-2958.1996.426965.x. [DOI] [PubMed] [Google Scholar]
  2. Chatfield S. N., Strahan K., Pickard D., Charles I. G., Hormaeche C. E., Dougan G. Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model. Microb Pathog. 1992 Feb;12(2):145–151. doi: 10.1016/0882-4010(92)90117-7. [DOI] [PubMed] [Google Scholar]
  3. Davies R., Kotlarski I. The role of thymus-derived cells in immunity to salmonella infection. Aust J Exp Biol Med Sci. 1976 Jun;54(3):221–236. doi: 10.1038/icb.1976.23. [DOI] [PubMed] [Google Scholar]
  4. Demarco de Hormaeche R., Jessop H., Bundell C. Antibodies to the C epitope of Neisseria gonorrhoeae are present in patients with gonorrhoea and absent in normal sera. J Gen Microbiol. 1988 May;134(5):1289–1297. doi: 10.1099/00221287-134-5-1289. [DOI] [PubMed] [Google Scholar]
  5. Demarco de Hormaeche R., Jessop H., Senior K. Gonococcal variants selected by growth in vivo or in vitro have antigenically different LPS. Microb Pathog. 1988 Apr;4(4):289–297. doi: 10.1016/0882-4010(88)90089-7. [DOI] [PubMed] [Google Scholar]
  6. Hess J., Ladel C., Miko D., Kaufmann S. H. Salmonella typhimurium aroA- infection in gene-targeted immunodeficient mice: major role of CD4+ TCR-alpha beta cells and IFN-gamma in bacterial clearance independent of intracellular location. J Immunol. 1996 May 1;156(9):3321–3326. [PubMed] [Google Scholar]
  7. Hoiseth S. K., Stocker B. A. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature. 1981 May 21;291(5812):238–239. doi: 10.1038/291238a0. [DOI] [PubMed] [Google Scholar]
  8. Hormaeche C. E. Natural resistance to Salmonella typhimurium in different inbred mouse strains. Immunology. 1979 Jun;37(2):311–318. [PMC free article] [PubMed] [Google Scholar]
  9. Izhar M., DeSilva L., Joysey H. S., Hormaeche C. E. Moderate immunodeficiency does not increase susceptibility to Salmonella typhimurium aroA live vaccines in mice. Infect Immun. 1990 Jul;58(7):2258–2261. doi: 10.1128/iai.58.7.2258-2261.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Johnson K., Charles I., Dougan G., Pickard D., O'Gaora P., Costa G., Ali T., Miller I., Hormaeche C. The role of a stress-response protein in Salmonella typhimurium virulence. Mol Microbiol. 1991 Feb;5(2):401–407. doi: 10.1111/j.1365-2958.1991.tb02122.x. [DOI] [PubMed] [Google Scholar]
  11. Mastroeni P., Arena A., Costa G. B., Liberto M. C., Bonina L., Hormaeche C. E. Serum TNF alpha in mouse typhoid and enhancement of a Salmonella infection by anti-TNF alpha antibodies. Microb Pathog. 1991 Jul;11(1):33–38. doi: 10.1016/0882-4010(91)90091-n. [DOI] [PubMed] [Google Scholar]
  12. Mastroeni P., Villarreal-Ramos B., Hormaeche C. E. Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells. Infect Immun. 1993 Sep;61(9):3981–3984. doi: 10.1128/iai.61.9.3981-3984.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mastroeni P., Villarreal-Ramos B., Hormaeche C. E. Role of T cells, TNF alpha and IFN gamma in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro- Salmonella vaccines. Microb Pathog. 1992 Dec;13(6):477–491. doi: 10.1016/0882-4010(92)90014-f. [DOI] [PubMed] [Google Scholar]
  14. McConkey G. A., Ittarat I., Meshnick S. R., McCutchan T. F. Auxotrophs of Plasmodium falciparum dependent on p-aminobenzoic acid for growth. Proc Natl Acad Sci U S A. 1994 May 10;91(10):4244–4248. doi: 10.1073/pnas.91.10.4244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Miller I. A., Chatfield S., Dougan G., Desilva L., Joysey H. S., Hormaeche C. Bacteriophage P22 as a vehicle for transducing cosmid gene banks between smooth strains of Salmonella typhimurium: use in identifying a role for aroD in attenuating virulent Salmonella strains. Mol Gen Genet. 1989 Jan;215(2):312–316. doi: 10.1007/BF00339734. [DOI] [PubMed] [Google Scholar]
  16. Nauciel C. Role of CD4+ T cells and T-independent mechanisms in acquired resistance to Salmonella typhimurium infection. J Immunol. 1990 Aug 15;145(4):1265–1269. [PubMed] [Google Scholar]
  17. Nauciel C., Ronco E., Pla M. Influence of different regions of the H-2 complex on the rate of clearance of Salmonella typhimurium. Infect Immun. 1990 Feb;58(2):573–574. doi: 10.1128/iai.58.2.573-574.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. O'Brien A. D., Metcalf E. S. Control of early Salmonella typhimurium growth in innately Salmonella-resistant mice does not require functional T lymphocytes. J Immunol. 1982 Oct;129(4):1349–1351. [PubMed] [Google Scholar]
  19. Stocker B. A. Aromatic-dependent Salmonella as live vaccine presenters of foreign epitopes as inserts in flagellin. Res Microbiol. 1990 Sep-Oct;141(7-8):787–796. doi: 10.1016/0923-2508(90)90112-4. [DOI] [PubMed] [Google Scholar]
  20. Strahan K., Chatfield S. N., Tite J., Dougan G., Hormaeche C. E. Impaired resistance to infection does not increase the virulence of Salmonella htrA live vaccines for mice. Microb Pathog. 1992 Apr;12(4):311–317. doi: 10.1016/0882-4010(92)90049-t. [DOI] [PubMed] [Google Scholar]
  21. Sztein M. B., Tanner M. K., Polotsky Y., Orenstein J. M., Levine M. M. Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans. J Immunol. 1995 Oct 15;155(8):3987–3993. [PubMed] [Google Scholar]
  22. Sztein M. B., Wasserman S. S., Tacket C. O., Edelman R., Hone D., Lindberg A. A., Levine M. M. Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J Infect Dis. 1994 Dec;170(6):1508–1517. doi: 10.1093/infdis/170.6.1508. [DOI] [PubMed] [Google Scholar]
  23. Tacket C. O., Sztein M. B., Losonsky G. A., Wasserman S. S., Nataro J. P., Edelman R., Pickard D., Dougan G., Chatfield S. N., Levine M. M. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect Immun. 1997 Feb;65(2):452–456. doi: 10.1128/iai.65.2.452-456.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Tite J. P., Dougan G., Chatfield S. N. The involvement of tumor necrosis factor in immunity to Salmonella infection. J Immunol. 1991 Nov 1;147(9):3161–3164. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES